DiscoverBecker’s Healthcare PodcastDr. Richard Pratley, Medical Director at AdventHealth Diabetes Institute
Dr. Richard Pratley, Medical Director at AdventHealth Diabetes Institute

Dr. Richard Pratley, Medical Director at AdventHealth Diabetes Institute

Update: 2024-06-25
Share

Description

In this episode, Dr. Richard Pratley, Medical Director at AdventHealth Diabetes Institute, discusses a groundbreaking study on Ozempic. Dr. Pratley shares insights from the global FLOW study, highlighting Ozempic's potential to reduce chronic kidney disease progression, cardiovascular events, and overall mortality in high-risk patients with type 2 diabetes.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Dr. Richard Pratley, Medical Director at AdventHealth Diabetes Institute

Dr. Richard Pratley, Medical Director at AdventHealth Diabetes Institute

Becker's Healthcare